Cargando…

The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study

SIMPLE SUMMARY: Radical treatment of prostate cancer (PCa) provides excellent oncological outcomes. However, curative treatment of primary PCa, as well as salvage treatment of biochemical recurrence after radical treatment, requires at least a 10-year life expectancy to be beneficial. To provide an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zapała, Piotr, Garbas, Karolina, Lewandowski, Zbigniew, Zapała, Łukasz, Ślusarczyk, Aleksander, Ślusarczyk, Cezary, Mielczarek, Łukasz, Radziszewski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454624/ https://www.ncbi.nlm.nih.gov/pubmed/36077673 http://dx.doi.org/10.3390/cancers14174135

Ejemplares similares

Neutrophil-to-lymphocyte ratio predicts nodal involvement in unfavourable, clinically nonmetastatic prostate cancer patients and overall survival in pN1 patients
por: Zapała, Piotr, et al.
Publicado: (2023)

Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians
por: Ślusarczyk, Aleksander, et al.
Publicado: (2021)

E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy
por: Zapała, Piotr, et al.
Publicado: (2021)

The Four-Feature Prognostic Models for Cancer-Specific and Overall Survival after Surgery for Localized Clear Cell Renal Cancer: Is There a Place for Inflammatory Markers?
por: Zapała, Łukasz, et al.
Publicado: (2022)

Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis
por: Zapała, Piotr, et al.
Publicado: (2023)

The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022)

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

The Role of Microbial Factors in Prostate Cancer Development—An Up-to-Date Review
por: Garbas, Karolina, et al.
Publicado: (2021)

The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial Cancer
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes
por: Hanusz, Karolina, et al.
Publicado: (2023)

The View Outside of the Box: Reporting Outcomes Following Radical Cystectomy Using Pentafecta From a Multicenter Retrospective Analysis
por: Zapała, Łukasz, et al.
Publicado: (2022)

The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
por: Miazek-Zapala, Nina, et al.
Publicado: (2021)

Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study
por: Mielczarek, Łukasz, et al.
Publicado: (2020)

Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms
por: Zapała, Łukasz, et al.
Publicado: (2022)

External validation of a magnetic resonance imaging-based algorithm for prediction of side-specific extracapsular extension in prostate cancer
por: Zapała, Piotr, et al.
Publicado: (2021)

Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern
por: Dybowski, Bartosz A., et al.
Publicado: (2018)

Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy
por: Lee, Joo Yong, et al.
Publicado: (2014)

Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
por: Park, Jae Won, et al.
Publicado: (2018)

New Kid on the Block: The Efficacy of Phytomedicine Extracts Urox(®) in Reducing Overactive Bladder Symptoms in Rats
por: Zapała, Łukasz, et al.
Publicado: (2022)

Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
por: Zapała, Łukasz, et al.
Publicado: (2021)

Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer
por: Zapała, Piotr, et al.
Publicado: (2018)

The Cannabinoid Ligand Arachidonyl-2′-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model
por: Zapała, Łukasz, et al.
Publicado: (2023)

Predicting side-specific prostate cancer extracapsular extension: a simple decision rule of PSA, biopsy, and MRI parameters
por: Zapała, Piotr, et al.
Publicado: (2019)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021)

The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres – results of CysTiming Poland study
por: Poletajew, Sławomir, et al.
Publicado: (2014)

Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
por: Zapała, Łukasz, et al.
Publicado: (2021)

Feasibility of active surveillance in small testicular mass: a mini review
por: Niemczyk, Grzegorz, et al.
Publicado: (2021)

Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate
por: Zapala, Piotr, et al.
Publicado: (2017)

Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
por: Furau, Alexandru, et al.
Publicado: (2021)

Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
por: Park, Jae Yoon, et al.
Publicado: (2015)

Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018)

Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
por: Hall, Ruth E., et al.
Publicado: (2019)

National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
por: Loyd, Christine, et al.
Publicado: (2021)

The prognostic value of the Charlson comorbidity index in aged patients with intracerebral hemorrhage
por: Zhang, Tianjie, et al.
Publicado: (2022)

Charlson comorbidity index applied to shunted idiopathic normal pressure hydrocephalus
por: Klinge, Petra M., et al.
Publicado: (2023)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum]
Publicado: (2023)

The Effect of Polypharmacy on the Charlson Comorbidity Index and Katz Index in Aging People with and without Diabetes Mellitus
por: Sahingoz Erdal, Gulcin, et al.
Publicado: (2021)

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy
por: Froehner, Michael, et al.
Publicado: (2014)

Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus
por: Zapała, Łukasz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btlnl77mrkdvibspdvbhioqr7p